Group One Trading
TCON

Group One Trading’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Group One Trading’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-16
Closed -$55 – 8381
2023
Q3 		$55 Hold
16
– – ﹤0.01% 7501
2023
Q2 		$91 Hold
16
– – ﹤0.01% 7518
2023
Q1 		$588 Hold
16
– – ﹤0.01% 6884
2022
Q4 		$463 Sell
16
-164
-91% -$4.96K ﹤0.01% 6957
2022
Q3 		$6K Hold
180
– – ﹤0.01% 6790
2022
Q2 		$7K Hold
180
– – ﹤0.01% 6966
2022
Q1 		$9K Buy
+180
New +$9.05K ﹤0.01% 7219
2021
Q3 		– Sell
-40
Closed -$3.39K – 8938
2021
Q2 		$5K Sell
40
-15
-27% -$2.08K ﹤0.01% 7788
2021
Q1 		$9K Buy
+55
New +$10.6K ﹤0.01% 7096

Other funds holding TCON

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Group One Trading's TCON Position: Q4 2023 in Review

Group One Trading sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q4 2023, closing a stake of 16 shares — an estimated $55 sold.

Group One Trading first reported a position in TCON in Q1 2021 and held it in 9 quarters. The position peaked at $9K in Q1 2022. 24 funds tracked by Wall St. Rank hold TCON as of Q4 2023.

  • Group One Trading reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 16 TRACON Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $55.
  • Group One Trading first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • Group One Trading's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $9K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.